The Division of Medicinal Chemistry and Natural Products will host a seminar
given by Stephen Frye, PhD, on Tuesday, August 28 at 1:00 p.m. in room
136 of the Turner-Tate-Kuralt Building. The seminar topic is "Gene Family
Science applied to Drug Discovery".

Frye recently left GlaxoSmithKline, where he was world wide vice
president for the High Throughput Chemistry and Discovery Medicinal
Chemistry, Molecular Discovery Research group. He received his BS in
chemistry from North Carolina State University in 1983 and his PhD in
chemistry from UNC-Chapel Hill in 1987. He joined Glaxo as a medicinal chemist in 1987 and remained with the company through its two mergers. Following the merger with GSK in the spring of 2000, he was selected to lead the High Throughput Chemistry group, which evolved into Discovery Medicinal Chemistry. In his seven years as the head of the DMC, the group grew to more than 200 chemists and developed global target-class chemical science and a compound-collection strategy that enhanced both the productivity and quality of GSK's hit-and-lead generation across all therapeutic areas.